Celularity Inc.

NASDAQ:CELU

2.41 (USD) • At close September 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -57.892-196.29514.192-100.118-208.233-211.881-13.375
Depreciation & Amortization 7.92211.4759.4368.8178.1746.1864.79
Deferred Income Tax 0000000
Stock Based Compensation 11.56915.01715.85640.014.3713.6684.501
Change In Working Capital 22.2-6.773-15.453-5.708-0.8030.94-1.342
Accounts Receivables -3.968-6.827-3.584-1.9091.6520.134-2.287
Inventory 6.284-0.865-16.891-6.422-0.643-1.708-3.403
Accounts Payables 9.239000000
Other Working Capital 10.6450.9195.0222.623-1.8122.5144.348
Other Non Cash Items 9.8137.891-161.907-53.097133.298134.294-54.543
Operating Cash Flow -6.401-38.685-137.876-110.096-63.193-1.098-0.001
Investing Activities:
Investments In Property Plant And Equipment -0.161-4.048-5.236-6.203-27.834-31.575-1.918
Acquisitions Net -1.500015.0190-29.281
Purchases Of Investments 00000-287.50
Sales Maturities Of Investments 0000000
Other Investing Activites 2.175000.300.6510.014
Investing Cash Flow 0.514-4.048-5.236-5.903-12.815-286.849-31.185
Financing Activities:
Debt Repayment 7.10211.31439.200-0.150
Common Stock Issued 0.0585.43453.3740.638102.673288.9890.025
Common Stock Repurchased 0000-0.25600
Dividends Paid 0000000
Other Financing Activities -0.4597.34627.26497.924102.13200
Financing Cash Flow 6.70124.094119.83898.562102.014288.8390.025
Other Information:
Effect Of Forex Changes On Cash 0000020.0950
Net Change In Cash 0.814-18.639-23.274-17.43726.0060.892-31.16
Cash At End Of Period 10.97710.16328.80252.07669.5130.9170.025